Comparative safety of the antifouling compound butenolide and 4,5-dichloro-2-n-octyl-4-isothiazolin-3-one (DCOIT) to the marine medaka (Oryzias melastigma)

• Published in: Aquatic toxicology 2014-04, Vol.149, p.116-125
• Main Authors: Chen, Lianguo, Ye, Rui, Xu, Ying, Gao, Zhaoming, Au, Doris W.T., Qian, Pei-Yuan
• Format: Article
• Language: English
• Subjects: 4-Butyrolactone - analogs & derivatives; Acetylcholinesterase - metabolism; Agnatha. Pisces; Animal, plant and microbial ecology; Animals; Antifouling; Applied ecology; Biological and medical sciences; Biomarkers - analysis; Butenolide; DCOIT; Ecotoxicology, biological effects of pollution; Effects of pollution and side effects of pesticides on vertebrates; Endocrine disruption; Enzyme Activation - drug effects; Estradiol - blood; Female; Freshwater; Fundamental and applied biological sciences. Psychology; Liver - drug effects; Male; Marine; Marine medaka; Oryzias - physiology; Oryzias latipes; Oryzias melastigma; Oxidative Stress - drug effects; Synaptic Transmission - drug effects; Testosterone - blood; Thiazoles - toxicity; Water Pollutants, Chemical - toxicity
• ISSN: 0166-445X; 1879-1514
• DOI: 10.1016/j.aquatox.2014.01.023

•Adverse effects of antifouling compound butenolide were studied using marine medaka.•The active ingredient in SeaNine 211, DCOIT, was employed as positive control.•Butenolide induced transient, reversible biological effects on marine medaka.•Lower toxicity of butenolide on marine biota highlights its promising application.•The increased sensitivity of male medaka addresses the gender difference. This study evaluated the potential adverse effects of butenolide, a promising antifouling compound, using the marine medaka (Oryzias melastigma), a model fish for marine ecotoxicology. The active ingredient used in the commercial antifoulant SeaNine 211, 4,5-dichloro-2-n-octyl-4-isothiazolin-3-one (DCOIT) was employed as the positive control. Adult marine medaka (4-month-old) were exposed to various concentrations of butenolide or DCOIT for 28 days and then depurated in clean seawater for 14 days (recovery). A suite of sensitive biomarkers, including hepatic oxidative stress, neuronal signal transmission, endocrine disruption, and reproductive function, was used to measure significant biological effects induced by the chemicals. Compared to DCOIT, chronic exposure to butenolide induced a lower extent of oxidative stress in the liver of male and female medaka. Furthermore, butenolide-exposed fish could recover faster from oxidative stress than fish exposed to DCOIT. Regarding neurotransmission, DCOIT significantly inhibited acetylcholinesterase (AChE) activity in the brain of both male and female medaka, whereas this was not significant for butenolide. In addition, plasma estradiol (E2) level was elevated and testosterone (T) level was decreased in male medaka exposed to DCOIT. This greatly imbalanced sex hormones ratio (E2/T) in exposed males, indicating that DCOIT is a potent endocrine disruptive chemical. In contrast, butenolide induced only moderate effects on sex hormone levels in exposed males, which could be gradually recovered during depuration. Moreover, the endocrine disruptive effect induced by butenolide did not affect normal development of offspring. In contrast, DCOIT-exposed fish exhibited a decrease of egg production and impaired reproductive success. Overall, the above findings demonstrated that chronic exposure to butenolide induced transient, reversible biological effect on marine medaka, while DCOIT could impair reproductive success of fish, as evident by clear alterations of the E2/T ratio. The relatively low toxicity of butenolide on marine bi